Astera Labs, Inc. ALAB
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.56B | 1.20B | 1.00B | 852.53M | 723.04M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.56B | 1.20B | 1.00B | 852.53M | 723.04M |
| Cost of Revenue | 406.31M | 298.92M | 240.45M | 207.26M | 177.80M |
| Gross Profit | 1.15B | 903.00M | 760.99M | 645.26M | 545.23M |
| SG&A Expenses | 226.56M | 195.30M | 171.94M | 167.84M | 171.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.16B | 928.47M | 777.47M | 679.10M | 616.43M |
| Operating Income | 397.10M | 273.45M | 223.97M | 173.42M | 106.61M |
| Income Before Tax | 447.18M | 322.02M | 269.85M | 218.15M | 149.94M |
| Income Tax Expenses | -14.14M | -47.48M | 2.23M | -981.00K | -48.93M |
| Earnings from Continuing Operations | 461.32 | 369.49 | 267.63 | 219.13 | 198.87 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 461.32M | 369.49M | 267.63M | 219.13M | 198.87M |
| EBIT | 397.10M | 273.45M | 223.97M | 173.42M | 106.61M |
| EBITDA | 412.62M | 285.40M | 233.39M | 180.25M | 111.57M |
| EPS Basic | 2.67 | 2.17 | 1.59 | 1.31 | 1.20 |
| Normalized Basic EPS | 1.62 | 1.18 | 1.00 | 0.82 | 0.57 |
| EPS Diluted | 2.51 | 2.02 | 1.48 | 1.22 | 1.11 |
| Normalized Diluted EPS | 1.53 | 1.11 | 0.93 | 0.76 | 0.52 |
| Average Basic Shares Outstanding | 686.74M | 680.05M | 673.10M | 665.56M | 655.95M |
| Average Diluted Shares Outstanding | 729.76M | 726.31M | 721.07M | 718.03M | 714.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |